Nous contacter
CURMED
(+41) 31 932 44 22
(+41) 31 932 40 29
Untere Zollgasse 28
CH-3072 Ostermundigen
Sélectionner une page
The Transverse Tibia Transport (TTT)-Treatment is a new surgical procedure which is based on the principles of Distraction Histogenesis (DH). With our TTT-System a small bone chip (5 x 1,5 cm) is slowly distracted transversely.
During the TTT-Treatment the body is generating his own Stem Cells and Growth Factors. The effect is not only locally but also systemically.
The TTT-Treatment promotes the self-regenerative potential of living tissue and also Neo-Vascularisation.
Schematic illustration of local and systemic responses during Distraction Histogenesis (DH).
At the site of distraction regenerate, expressions of various molecules including BMPs, inflammatory cytokines and angiogenic factors are regulated through during mechanotransduction.
Furthermore, systemic effects of DH also contribute to musculoskeletal regeneration.
This Tibial Transverse Transport System is designed for advance the treatment of diabetic foot ulcer and peripheral avascular conditions. Due to its versatility, the system is specifically indicated for:
— Diabetic foot with I to Ill grade ulcer (DFU)
— Buerger disease (TAO)
— Arterio sclerosis obliterans (ASO)
Loss of popliteal artery pulse.
Other general contraindication for external fixators
In a prospective clinical study of 123 patients at a leading US Hospital system using the MSIS-13 criteria as comparator, the Lyfstone Calprotectin test showed excellent sensitivity (98.1%) and specificity (95.7%). The calprotectin test outperformed blood-based PJI diagnostic tests such as CRP and ESR, confirming its diagnostic utility. Source: Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection after Total Knee
| plus d’informations
informations détaillées par le fabricant |
Questions? Remarques?
info@curmed.ch |
Untere Zollgasse 28
CH-3072 Ostermundigen
